Inspire Medical Systems, Inc.
INSP
$81.79
-$2.02-2.41%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 224.50M | 217.09M | 201.32M | 239.72M | 203.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 224.50M | 217.09M | 201.32M | 239.72M | 203.19M |
| Cost of Revenue | 31.77M | 34.67M | 30.71M | 35.99M | 32.40M |
| Gross Profit | 192.73M | 182.41M | 170.61M | 203.73M | 170.79M |
| SG&A Expenses | 158.87M | 159.52M | 144.29M | 141.51M | 130.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 214.86M | 220.40M | 202.80M | 207.83M | 188.87M |
| Operating Income | 9.64M | -3.32M | -1.49M | 31.88M | 14.32M |
| Income Before Tax | 13.55M | -2.33M | 4.16M | 36.64M | 20.33M |
| Income Tax Expenses | 3.62M | 1.26M | 1.17M | 1.41M | 1.83M |
| Earnings from Continuing Operations | 9.93M | -3.59M | 2.99M | 35.22M | 18.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.93M | -3.59M | 2.99M | 35.22M | 18.50M |
| EBIT | 9.64M | -3.32M | -1.49M | 31.88M | 14.32M |
| EBITDA | 13.32M | 98.00K | 1.56M | 34.36M | 16.17M |
| EPS Basic | 0.34 | -0.12 | 0.10 | 1.18 | 0.62 |
| Normalized Basic EPS | 0.37 | 0.04 | 0.09 | 0.77 | 0.43 |
| EPS Diluted | 0.34 | -0.12 | 0.10 | 1.14 | 0.60 |
| Normalized Diluted EPS | 0.37 | 0.04 | 0.09 | 0.74 | 0.41 |
| Average Basic Shares Outstanding | 29.33M | 29.51M | 29.70M | 29.83M | 29.88M |
| Average Diluted Shares Outstanding | 29.60M | 29.51M | 30.31M | 30.75M | 30.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |